此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

认知运动疗法和瑜伽对痛经青少年的疗效

2026年8月25日 更新者:Dilek Cagri、Acibadem University

基于远程康复的认知运动疗法和瑜伽对痛经青少年疼痛、身体功能和生活质量的影响

痛经是一种对许多年龄段女性的生活质量产生负面影响的疾病。 对于青春期患有痛经的女孩来说,疼痛会影响学业表现、自信心抑郁问题以及生活质量下降。 为了消除这些负面影响,他们应该接受良好的治疗。 医疗通常试图尽量减少和平衡这种情况。 考虑到家庭不愿意让这个年龄段的孩子使用口服避孕药等药物,以及口服避孕药的风险,家长们都在不同的寻找。 考虑到治疗疼痛应始终从整体角度出发,瑜伽和认知运动疗法都是身心完整性范围内的生物心理社会治疗方法。 瑜伽和认知运动疗法被认为可以减轻青春期女孩的症状,改善身体机能和生活质量。 有了这些积极的影响,缺课率就会减少,抑郁症和自信心也会提高。 健康成本也会得到一定程度的降低。

研究概览

详细说明

本研究被设计为一项前瞻性、随机、对照、平行组研究。

该研究的对象包括在伊斯坦布尔寻求妇产科专家治疗的患者。

G-Power 统计和定性数据分析软件版本 3.1.9.2 用于估计研究所需的样本量。 考虑到该研究总共由三个平行组组成,在三个不同时间点进行测量,且效应大小f=0.25, α误差水平0.05,功效(1-β误差水平)0.80,总样本量计算为36。 当估计可能失访的受试者比例为20%时,计算出至少45名受试者应纳入研究。

第一个干预组将接受认知运动疗法,第二个干预组将接受瑜伽,第三个对照组将接受常规医疗。 为了充分证明干预措施的有效性,减少偏差并确保训练组和对照组之间的同质性,各组的分配将在随机组织中确定。 程序。

瑜伽和认知运动疗法将由在这两个领域接受过培训的物理治疗师应用。 治疗将每周持续两次,持续 12 周。 对病例进行初步评估后,第一周将进行一对一、面对面的培训(2次),以确保患者对治疗的依从性和充分了解治疗方法。 之后,每周两次通过在线平台(Zoom)与患者同步进行治疗。

评估将在治疗前、第6周和第12周进行3次。 所有评估都将在相关诊所面对面进行。

研究类型

介入性

注册 (估计的)

45

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人

接受健康志愿者

不

描述

纳入标准:

  • 经妇产科医生诊断为痛经,
  • 年龄在10-19岁之间,
  • 能够读写土耳其语,
  • 自愿参加这项研究。

排除标准:

  • 被诊断为继发性痛经,
  • 被诊断出患有另一种妇科疾病,
  • 患有严重的合并症(神经和/或心血管和/或肌肉骨骼疾病、精神病、胃肠道、自身免疫性疾病),
  • 去年有涉及腹部、盆腔和脊柱的手术史,
  • 以前有瑜伽和认知运动疗法的经验,
  • 积极参与另一项研究的人将不会被纳入该研究。

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:认知运动疗法
认知运动治疗课程将包括在一个疗程中进行各种运动的练习,这些练习将在物理治疗师的陪同下进行呼吸控制。
它将每周持续两次,持续 12 周。 对病例进行初步评估后,第一周(2次)将与患者进行一对一的面对面培训,以确保患者对治疗的依从性并充分了解治疗方法。 然后,每周两次通过在线平台(Zoom)与患者同步进行治疗。
实验性的:瑜伽课程
瑜伽课程将包括一系列练习,其中包括一次练习中的各种动作,并且练习将在物理治疗师的陪同下进行呼吸控制练习。
它将每周持续两次,持续 12 周。 对病例进行初步评估后,第一周(2次)将与患者进行一对一的面对面培训,以确保患者对治疗的依从性并充分了解治疗方法。 然后,每周两次通过在线平台(Zoom)与患者同步进行治疗。
其他:Routine Medical Treatment
Participants in this group continue to receive the routine medical treatment recommended by their physician. No structured exercise programme or education is provided within the scope of the study.
对该组中的个人的评估将在相关诊所进行面对面的评估。

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Pain intensity (VAS)
大体时间:Baseline and each menstrual cycle occurring during the 12-week intervention period (approximately three cycles)
In the 10 cm VAS, which is the most widely used, reliable and valid scale in the evaluation of pain intensity all over the world, the left end of the line will be formed as "0 = no pain" and the other end as "10 = unbearable pain". The subjects will be given paper in the form of a pain diary to mark during their menstrual periods and will be asked to mark the point appropriate to the intensity of pain 2 days before, 1 day before, on the 1st, 2nd and 3rd day of menstruation.
Baseline and each menstrual cycle occurring during the 12-week intervention period (approximately three cycles)

次要结果测量

结果测量
措施说明
大体时间
身体机能(灵活性)
大体时间:进行3次:治疗前、第6周和第12周。
坐姿前伸测试:参与研究的受试者的灵活性将使用标准坐姿前伸箱(Sit and Reach Trunk Flexibility Assessment Test Box,Baseline,NY,USA)进行评估。
进行3次:治疗前、第6周和第12周。
身体机能(周围肌肉力量)
大体时间:进行3次:治疗前、第6周和第12周。
周围肌肉力量:为了评估受试者的周围肌肉力量,将使用手持式测力计评估双腿的髋部屈肌、髋部伸肌和髋部外展肌。
进行3次:治疗前、第6周和第12周。
身体功能(心率变异性)
大体时间:这将进行3次:在治疗之前,第6周和第12周。
心率变异性:心率变异性(HRV)定义了心率的自主性调节。 它反映了副交感神经和交感/副交感神经系统平衡。 神经影像学研究表明,伤害感受刺激与自主神经系统活动密切相关。 疼痛会导致副交感神经活动的减少,交感神经活动的增加和交感神经失衡。 由交感神经过度活动引起的自主神经系统失衡可能是主要痛经的另一个原因。 为了应对外部环境的变化,ANS通过交感神经和副交感神经之间的相互作用来维持人体内部环境的体内平衡。 两个系统之间缺乏协调会导致各种症状。 由于这些原因,使用Polar H10设备将在患有原发性痛经的青少年女孩中测量和记录心率变异性。
这将进行3次:在治疗之前,第6周和第12周。
Education absenteeism
大体时间:This procedure will be performed 3 times: through study completion, an average of 3 months
Adolescents with dysmenorrhea are typically of school age and may miss several days of school due to dysmenorrhea experienced during their menstrual periods. Therefore, the school absences of participants in the study will be monitored throughout the process. School absence rates before and after treatment will be compared.
This procedure will be performed 3 times: through study completion, an average of 3 months
Depression, anxiety, stress level
大体时间:It will be done 2 times: before the treatment and 12 weeks after the treatment.
Depression-Anxiety-Stress Scale Short Form (DASS-21): Both the original 42-item version of the DASS and the shorter 21-item version have been shown to be reliable and valid scales for measuring depression, anxiety and stress levels, through studies conducted with clinical groups, society and different cultural and ethnic groups. 7 items of DASS-21 include questions about depression, 7 items about anxiety, and 7 items about stress. Each subscale (depression, anxiety, stress) has a minimum of 0 and a maximum of 21 points. A low score indicates a good psychological state.
It will be done 2 times: before the treatment and 12 weeks after the treatment.
Dysmenorrhea Impact
大体时间:It will be done 2 times: before the treatment and 12 weeks after the treatment.
Revised Dysmenorrhea Impact Scale-Short Form (DIS-R): This 13-item scale, which includes cognitive/emotional (8 items) and physiological (5 items) subscales, has been shown to be a valid and reliable measurement tool. The minimum score on the scale is 0 and the maximum score is 65. As the scores increase, the functional and emotional impact level of individuals with dysmenorrhea also increases.
It will be done 2 times: before the treatment and 12 weeks after the treatment.
Physical activity
大体时间:It will be done 2 times: before the treatment and 12 weeks after the treatment.
Physical Activity Questionnaire for Adolescents (PAQ-A): Designed to provide a general estimate of physical activity levels among healthy adolescents, assessing sports participation and activities during and after school, self-administered and based on the last week. Later, a modified form for adolescents was published. The Turkish validity and reliability study of the scale was conducted. 8 questions in the scale are scored between 1 and 5, and the 9th question questions the presence of a condition that prevents physical activity during the last week. A score of '1' corresponds to low-intensity physical activity and a score of '5' corresponds to high-intensity physical activity, but the last question is not included in the scoring. The total score is obtained by calculating the average score of all questions.
It will be done 2 times: before the treatment and 12 weeks after the treatment.
Patient satisfaction
大体时间:This procedure will be performed once: at the 12th week after treatment.

The question of whether a patient is improving is fundamental in clinical practice, and the information obtained is important in making decisions regarding prognosis and treatment. Global Rating of Change (GROC) scales are widely used in clinical research, especially in the field of the musculoskeletal system. These scales are a rapid, effective method designed to measure a patient's improvement or worsening over time, usually either to determine the effect of an intervention or to chart the clinical course of a condition.

In our study, to measure treatment satisfaction, "-2" means "I am very bad compared to before treatment", "-1" means "I am worse than before treatment", "0" means there is no change compared to before treatment, "1" means I am better than before treatment, "2" means I am very better than before treatment. The Global Rating of Change (GROC) scale will be used in the five-point Likert system.

This procedure will be performed once: at the 12th week after treatment.
Adolescent quality of life
大体时间:It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Pediatric Quality of Life Inventory TM (PedsQL)(Adolescent Form): The PedsQL is a quality of life scale that is suitable for use in both healthy and diseased children and adolescents. The PedsQL consists of child and parent forms aged 2-18 years. Since the adolescent group will be included in this study, the 13-18 years old. Adolescent Form will be used. Scoring is done in 3 areas. Firstly, the total scale score (TSS), secondly, the total physical health score (PHSS), and thirdly, the total psychosocial health score (TPHSS), which consists of the calculation of item scores evaluating emotional, social and school functionality, are calculated. The items are scored between 0-100. If the answer to the question is marked as never, 100 points are scored; if it is marked as rarely, 75 points are scored; if it is marked as sometimes, 50 points are scored; if it is marked as frequently, 25 points are scored; if it is marked as almost always, 0 points are scored.
It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Menstrual symptom questionnaire
大体时间:It will be done 2 times: before the treatment and 12 weeks after the treatment.
The Menstrual Symptom Questionnaire (MSQ) is a 22-item, five-point Likert-type scale developed by Chesney et al. to assess menstrual pain and symptoms. The Turkish validity and reliability study of the scale was conducted by Güvenç et al. in 2014. The scale has three sub-dimensions: "Negative Effects/Somatic Complaints", "Menstrual Pain", and "Menstrual Pain Coping Methods". The results obtained from the internal consistency coefficient, test-retest reliability coefficient, exploratory factor analysis, and criterion-related validity analyses show that the validity and reliability findings of the MSQ in Turkish are at a sufficient level and that it can be used to assess menstrual symptoms in Turkish adolescents. The MSQ score is calculated by taking the average total score of the items in the scale.
It will be done 2 times: before the treatment and 12 weeks after the treatment.
Menstrual attitude questionnaire
大体时间:It will be done 2 times: before the treatment and 12 weeks after the treatment.
The Menstrual Attitude Scale (MAS), a Likert-type scale consisting of 33 items and 5 subcategories, was developed by Brooks-Gunn and Ruble (1980). The Turkish validity and reliability study of the scale was conducted by Kulakaç et al. in 2008. Due to the difficulty in adapting the original 7-point Likert-type rating form to Turkish, it was converted into a 5-point rating form ranging from 1 to 5 (1. Strongly disagree, 2. Disagree, 3. Undecided, 4. Agree, 5. Strongly agree) in the Turkish form. While the original scale consisted of 33 items, two items were removed during the Turkish adaptation due to their low factor loadings. As a result, the scale consists of 31 items and five sub-dimensions. Overall, the MAS provides information about how women cope with menstrual situations and their attitudes towards menstruation. A high average score from the subgroups or the entire scale indicates a "positive" attitude towards menstruation.
It will be done 2 times: before the treatment and 12 weeks after the treatment.
Forced vital capacity (FVC)
大体时间:It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Pulmonary function was assessed by spirometry in accordance with American Thoracic Society (ATS)/European Respiratory Society (ERS) standards. Forced vital capacity (FVC) was measured and recorded.
It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Forced expiratory volume in 1 second (FEV1)
大体时间:It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Pulmonary function was assessed by spirometry in accordance with ATS/ERS standards. Forced expiratory volume in the first second (FEV1) was measured and recorded.
It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
FEV1/FVC ratio
大体时间:It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Pulmonary function was assessed by spirometry in accordance with ATS/ERS standards. The ratio of FEV1 to FVC was calculated and recorded.
It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Peak expiratory flow (PEF)
大体时间:It will be done 3 times: before the treatment, at the 6th week and at the 12th week.
Pulmonary function was assessed by spirometry in accordance with ATS/ERS standards. Peak expiratory flow (PEF) was measured and recorded.
It will be done 3 times: before the treatment, at the 6th week and at the 12th week.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Dilek Çağrı Arslan, Lecturer、Acibadem University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年12月1日

初级完成 (估计的)

2026年12月1日

研究完成 (估计的)

2026年12月1日

研究注册日期

首次提交

2024年4月3日

首先提交符合 QC 标准的

2024年5月1日

首次发布 (实际的)

2024年5月3日

研究记录更新

最后更新发布 (实际的)

2026年8月27日

上次提交的符合 QC 标准的更新

2026年8月25日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

研究结束时,将统计给出参与者的一般数据结果。 单独的数据集不会被共享。

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅